TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OSCILLOTHERAPY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OSCILLOTHERAPY

ST13

US500000097534278

Classe

10, 44

Pedido

97534278

Registro

8036072

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

26/11/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 44

Data de depósito

04/08/2022

Data de registro

25/11/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/11/2025

Última transação

26/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

77

Localização do titular

Szeged, HU

Examinador

LAMONT,JOHN CHRISTOPHER

Unidade examinadora

N50

Localização atual

INTENT TO USE SECTION

Titulares e representantes

Titulares

N. Z. (pessoa física)

Representantes

David S. Safran Calderon Safran & Wright P.C.

Classificação técnica

Classes Nice

Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Medical and veterinary apparatus and instruments, namely, neurostimulators; Diagnostic, examination, and monitoring equipment, namely, patient monitoring sensors and alarms; Apparatus for the diagnosis and treatment of neurological diseases; Apparatus for the treatment of diseases of the nervous system, namely, epilepsy, seizures, depression, anxiety, post-traumatic stress disorders, trauma-related mental disorders, Parkinson's disease and syndrome, Alzheimer's disease, addiction disorders and schizophrenia; Apparatus for the treatment of disorders of the brain, namely, epilepsy, seizure, depression, anxiety, post-traumatic stress disorders, trauma-related mental disorders, Parkinson's disease and syndrome, Alzheimer's disease, addiction disorders and schizophrenia; Medical apparatus for the automated detection and early seizure-termination of pharmaceutically intractable epilepsies; Electrical neuromodulation instruments and apparatus for medical use; Transcutaneous electrical nerve stimulators for medical purposes; electrical nerve stimulators for medical purposes; Electronic monitoring instruments for medical use, namely, brain wave monitors and detectors; Apparatus for the treatment of neuropsychiatric disorders, namely, Intersectional Short Pulse stimulation apparatus, transcutaneous, subcutaneous and subgaleal transcranial electrical stimulation apparatus and intracranial electrical stimulation apparatus

Classe 44

Human healthcare services; Mental health services; Medical services; Medical services in the field of treatment of the disorder of the brain; Medical services in the field of neurological diseases; Health care services for treating epilepsy; Health care services in the field of psychiatric diseases; Providing electrical neuromodulation therapy for treating medical/neurological conditions; Medical testing services relating to the diagnosis and treatment of disease; Medical testing services relating to the diagnosis and treatment of neurological disease; Digital healthcare services being telemedicine services; Advisory services relating to the treatment of neurological diseases; Health screening in the field of neurological and neuropsychiatric disorders; Medical and healthcare clinics; Medical services for the treatment of neurological diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

25/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

25/11/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

05/11/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/11/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/05/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

07/05/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/04/2025

EX1G

SOU EXTENSION 1 GRANTED

08/04/2025

EXT1

SOU EXTENSION 1 FILED

08/04/2025

EEXT

SOU TEAS EXTENSION RECEIVED

08/04/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/04/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/04/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/04/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/04/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

29/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/09/2024

PUBO

PUBLISHED FOR OPPOSITION

03/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

14/08/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

16/02/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/02/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

14/02/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/02/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

14/02/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/01/2024

ALIE

ASSIGNED TO LIE

16/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/08/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/05/2023

GNRT

NON-FINAL ACTION E-MAILED

25/05/2023

CNRT

NON-FINAL ACTION WRITTEN

25/05/2023

DOCK

ASSIGNED TO EXAMINER

23/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

25/08/2022

NWAP

NEW APPLICATION ENTERED

08/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OSCILLOTHERAPY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.